https://www.oncotarget.com/
Peer-reviewed Oncology & Cancer Research Journal | Oncotarget
Oncotarget is a peer-reviewed, open-access oncology journal indexed in PubMed/MEDLINE and Scopus. Publishing cutting-edge cancer research since 2010. ISSN:...
peer reviewedcancer researchoncologyjournaloncotarget
https://www.oncotarget.org/misha-blagosklonny/
Misha Blagosklonny | Oncotarget.org | cancer, rapamycin, aging, hyperfunction theory, immortality
May 13, 2025 - Misha Blagosklonny, M.D., Ph.D. is a founder and Editor-in-Chief at Oncotarget and Aging, an Editor-in-Chief at Oncoscience, and an editor at Genes and Cancer....
mishaoncotargetcancerrapamycinaging
https://www.brightsurf.com/news/8OM03DN1/oncotarget-polyisoprenylated-cysteinyl-amide-inhibitors-deplete-g-proteins-in-cancer-cells.html
Oncotarget | Polyisoprenylated cysteinyl amide inhibitors deplete g-proteins in cancer cells |...
Researchers found significant decreases in the levels of KRAS, RHOA, RAC1, and CDC42 after PCAI treatment, implicating their role in cancer progression and...
in canceroncotargetinhibitorsdepleteproteins
https://ecancer.org/en/news/18873-oncotarget-th1-cytokines-potentiate-apoptosis-of-breast-cancer-cells-and-suppress-tumour-growth
Oncotarget: Th1 cytokines potentiate apoptosis of breast cancer cells and suppress tumour growth -...
Volume 11, Issue 30 of Oncotarget reported that previously, the authors showed that anti-estrogen drugs combined with a dendritic cell-based anti-HER-2 vacci
breast canceroncotargetcytokinespotentiateapoptosis
https://bioweb.supagro.inrae.fr/ESTHER/paper/Choi_2016_Oncotarget_7_75319
Choi_2016_Oncotarget_7_75319
choioncotarget